SARTORIUS AG-VORZUG (SRT3.DE) Fundamental Analysis & Valuation
FRA:SRT3 • DE0007165631
Current stock price
217.2 EUR
+7.9 (+3.77%)
Last:
This SRT3.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. SRT3.DE Profitability Analysis
1.1 Basic Checks
- SRT3 had positive earnings in the past year.
- In the past year SRT3 had a positive cash flow from operations.
- SRT3 had positive earnings in each of the past 5 years.
- SRT3 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- SRT3's Return On Assets of 1.65% is on the low side compared to the rest of the industry. SRT3 is outperformed by 68.75% of its industry peers.
- The Return On Equity of SRT3 (5.97%) is worse than 68.75% of its industry peers.
- The Return On Invested Capital of SRT3 (5.11%) is worse than 68.75% of its industry peers.
- SRT3 had an Average Return On Invested Capital over the past 3 years of 4.49%. This is below the industry average of 7.18%.
- The 3 year average ROIC (4.49%) for SRT3 is below the current ROIC(5.11%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.65% | ||
| ROE | 5.97% | ||
| ROIC | 5.11% |
ROA(3y)1.51%
ROA(5y)3.97%
ROE(3y)6.23%
ROE(5y)15.62%
ROIC(3y)4.49%
ROIC(5y)9.01%
1.3 Margins
- SRT3's Profit Margin of 4.58% is on the low side compared to the rest of the industry. SRT3 is outperformed by 62.50% of its industry peers.
- SRT3's Profit Margin has declined in the last couple of years.
- The Operating Margin of SRT3 (15.73%) is comparable to the rest of the industry.
- SRT3's Operating Margin has declined in the last couple of years.
- Looking at the Gross Margin, with a value of 45.59%, SRT3 is in the better half of the industry, outperforming 68.75% of the companies in the same industry.
- In the last couple of years the Gross Margin of SRT3 has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.73% | ||
| PM (TTM) | 4.58% | ||
| GM | 45.59% |
OM growth 3Y-16.16%
OM growth 5Y-5.98%
PM growth 3Y-35.4%
PM growth 5Y-13.41%
GM growth 3Y-3.93%
GM growth 5Y-2.18%
2. SRT3.DE Health Analysis
2.1 Basic Checks
- SRT3 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- The number of shares outstanding for SRT3 remains at a similar level compared to 1 year ago.
- Compared to 5 years ago, SRT3 has more shares outstanding
- SRT3 has a better debt/assets ratio than last year.
2.2 Solvency
- SRT3 has an Altman-Z score of 2.23. This is not the best score and indicates that SRT3 is in the grey zone with still only limited risk for bankruptcy at the moment.
- SRT3 has a Altman-Z score (2.23) which is comparable to the rest of the industry.
- The Debt to FCF ratio of SRT3 is 9.70, which is on the high side as it means it would take SRT3, 9.70 years of fcf income to pay off all of its debts.
- With a Debt to FCF ratio value of 9.70, SRT3 is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
- SRT3 has a Debt/Equity ratio of 1.22. This is a high value indicating a heavy dependency on external financing.
- SRT3's Debt to Equity ratio of 1.22 is on the low side compared to the rest of the industry. SRT3 is outperformed by 81.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | 9.7 | ||
| Altman-Z | 2.23 |
ROIC/WACC0.6
WACC8.54%
2.3 Liquidity
- A Current Ratio of 0.91 indicates that SRT3 may have some problems paying its short term obligations.
- SRT3 has a Current ratio of 0.91. This is amonst the worse of the industry: SRT3 underperforms 87.50% of its industry peers.
- A Quick Ratio of 0.52 indicates that SRT3 may have some problems paying its short term obligations.
- SRT3 has a worse Quick ratio (0.52) than 87.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.91 | ||
| Quick Ratio | 0.52 |
3. SRT3.DE Growth Analysis
3.1 Past
- SRT3 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.48%, which is quite good.
- SRT3 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.76% yearly.
- Looking at the last year, SRT3 shows a small growth in Revenue. The Revenue has grown by 3.20% in the last year.
- SRT3 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.66% yearly.
EPS 1Y (TTM)11.48%
EPS 3Y-20.66%
EPS 5Y1.76%
EPS Q2Q%-1.64%
Revenue 1Y (TTM)3.2%
Revenue growth 3Y-5.37%
Revenue growth 5Y8.66%
Sales Q2Q%1.82%
3.2 Future
- The Earnings Per Share is expected to grow by 16.14% on average over the next years. This is quite good.
- SRT3 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.11% yearly.
EPS Next Y19.16%
EPS Next 2Y18.45%
EPS Next 3Y18.59%
EPS Next 5Y16.14%
Revenue Next Year6.1%
Revenue Next 2Y7.92%
Revenue Next 3Y8.69%
Revenue Next 5Y9.11%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. SRT3.DE Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 45.63, the valuation of SRT3 can be described as expensive.
- Based on the Price/Earnings ratio, SRT3 is valued a bit more expensive than 75.00% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 26.64, SRT3 is valued quite expensively.
- The Price/Forward Earnings ratio is 32.39, which means the current valuation is very expensive for SRT3.
- Based on the Price/Forward Earnings ratio, SRT3 is valued a bit more expensive than 75.00% of the companies in the same industry.
- SRT3's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 45.63 | ||
| Fwd PE | 32.39 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, SRT3 is valued more expensive than 81.25% of the companies in the same industry.
- SRT3's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 36.7 | ||
| EV/EBITDA | 20.3 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- SRT3's earnings are expected to grow with 18.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.38
PEG (5Y)25.88
EPS Next 2Y18.45%
EPS Next 3Y18.59%
5. SRT3.DE Dividend Analysis
5.1 Amount
- With a yearly dividend of 0.42%, SRT3 is not a good candidate for dividend investing.
- SRT3's Dividend Yield is comparable with the industry average which is at 0.58.
- With a Dividend Yield of 0.42, SRT3 pays less dividend than the S&P500 average, which is at 1.80.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.42% |
5.2 History
- The dividend of SRT3 is nicely growing with an annual growth rate of 15.65%!
Dividend Growth(5Y)15.65%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 62.38% of the earnings are spent on dividend by SRT3. This is not a sustainable payout ratio.
- SRT3's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP62.38%
EPS Next 2Y18.45%
EPS Next 3Y18.59%
SRT3.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:SRT3 (4/30/2026, 5:36:15 PM)
217.2
+7.9 (+3.77%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Industry Strength10.81
Industry Growth92
Earnings (Last)04-23 2026-04-23/bmo
Earnings (Next)07-23 2026-07-23
Inst Owners1.97%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap16.26B
Revenue(TTM)3.55B
Net Income(TTM)162.70M
Analysts80
Price Target389.37 (79.27%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.42% |
Yearly Dividend0.73
Dividend Growth(5Y)15.65%
DP62.38%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.56%
Min EPS beat(2)-10.67%
Max EPS beat(2)7.55%
EPS beat(4)2
Avg EPS beat(4)-2.2%
Min EPS beat(4)-10.67%
Max EPS beat(4)7.55%
EPS beat(8)3
Avg EPS beat(8)-1.57%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.41%
Min Revenue beat(2)-1.05%
Max Revenue beat(2)0.24%
Revenue beat(4)2
Avg Revenue beat(4)-0.18%
Min Revenue beat(4)-1.05%
Max Revenue beat(4)0.83%
Revenue beat(8)5
Avg Revenue beat(8)0.68%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.43%
PT rev (3m)0.61%
EPS NQ rev (1m)-8.44%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.19%
EPS NY rev (3m)-5.86%
Revenue NQ rev (1m)-0.56%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.83%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 45.63 | ||
| Fwd PE | 32.39 | ||
| P/S | 4.58 | ||
| P/FCF | 36.7 | ||
| P/OCF | 18.34 | ||
| P/B | 5.96 | ||
| P/tB | N/A | ||
| EV/EBITDA | 20.3 |
EPS(TTM)4.76
EY2.19%
EPS(NY)6.71
Fwd EY3.09%
FCF(TTM)5.92
FCFY2.73%
OCF(TTM)11.84
OCFY5.45%
SpS47.47
BVpS36.41
TBVpS-34.21
PEG (NY)2.38
PEG (5Y)25.88
Graham Number62.4486 (-71.25%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.65% | ||
| ROE | 5.97% | ||
| ROCE | 7.2% | ||
| ROIC | 5.11% | ||
| ROICexc | 5.54% | ||
| ROICexgc | 21.21% | ||
| OM | 15.73% | ||
| PM (TTM) | 4.58% | ||
| GM | 45.59% | ||
| FCFM | 12.47% |
ROA(3y)1.51%
ROA(5y)3.97%
ROE(3y)6.23%
ROE(5y)15.62%
ROIC(3y)4.49%
ROIC(5y)9.01%
ROICexc(3y)4.83%
ROICexc(5y)9.64%
ROICexgc(3y)16.7%
ROICexgc(5y)28.15%
ROCE(3y)6.33%
ROCE(5y)12.7%
ROICexgc growth 3Y-19.62%
ROICexgc growth 5Y-7.23%
ROICexc growth 3Y-29.84%
ROICexc growth 5Y-12.08%
OM growth 3Y-16.16%
OM growth 5Y-5.98%
PM growth 3Y-35.4%
PM growth 5Y-13.41%
GM growth 3Y-3.93%
GM growth 5Y-2.18%
F-Score7
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | 9.7 | ||
| Debt/EBITDA | 3.4 | ||
| Cap/Depr | 104.8% | ||
| Cap/Sales | 12.48% | ||
| Interest Coverage | 3.05 | ||
| Cash Conversion | 90.28% | ||
| Profit Quality | 272.4% | ||
| Current Ratio | 0.91 | ||
| Quick Ratio | 0.52 | ||
| Altman-Z | 2.23 |
F-Score7
WACC8.54%
ROIC/WACC0.6
Cap/Depr(3y)122.42%
Cap/Depr(5y)145.08%
Cap/Sales(3y)13.7%
Cap/Sales(5y)13.08%
Profit Quality(3y)357.39%
Profit Quality(5y)249.46%
High Growth Momentum
Growth
EPS 1Y (TTM)11.48%
EPS 3Y-20.66%
EPS 5Y1.76%
EPS Q2Q%-1.64%
EPS Next Y19.16%
EPS Next 2Y18.45%
EPS Next 3Y18.59%
EPS Next 5Y16.14%
Revenue 1Y (TTM)3.2%
Revenue growth 3Y-5.37%
Revenue growth 5Y8.66%
Sales Q2Q%1.82%
Revenue Next Year6.1%
Revenue Next 2Y7.92%
Revenue Next 3Y8.69%
Revenue Next 5Y9.11%
EBIT growth 1Y37.28%
EBIT growth 3Y-20.66%
EBIT growth 5Y2.17%
EBIT Next Year81.03%
EBIT Next 3Y32.63%
EBIT Next 5Y24.44%
FCF growth 1Y205.87%
FCF growth 3Y23.14%
FCF growth 5Y7.81%
OCF growth 1Y27.16%
OCF growth 3Y4.46%
OCF growth 5Y10.35%
SARTORIUS AG-VORZUG / SRT3.DE Fundamental Analysis FAQ
What is the ChartMill fundamental rating of SARTORIUS AG-VORZUG (SRT3.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to SRT3.DE.
Can you provide the valuation status for SARTORIUS AG-VORZUG?
ChartMill assigns a valuation rating of 1 / 10 to SARTORIUS AG-VORZUG (SRT3.DE). This can be considered as Overvalued.
What is the profitability of SRT3 stock?
SARTORIUS AG-VORZUG (SRT3.DE) has a profitability rating of 3 / 10.
Can you provide the expected EPS growth for SRT3 stock?
The Earnings per Share (EPS) of SARTORIUS AG-VORZUG (SRT3.DE) is expected to grow by 19.16% in the next year.
Can you provide the dividend sustainability for SRT3 stock?
The dividend rating of SARTORIUS AG-VORZUG (SRT3.DE) is 3 / 10 and the dividend payout ratio is 62.38%.